Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 b Randomized, Double-blind, Placebo-Controlled, Experimental Medicine Study of Fosigotifator in Adults With Major Depressive Disorder

NCT06618118 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06618118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06618118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 b Randomized, Double-blind, Placebo-Controlled, Experimental Medicine Study of Fosigotifator in Adults With Major Depressive Disorder
Lead sponsor
AbbVie
Phase
Phase 1
Overall status
Terminated
Start date
October 23, 2024
Completion date
September 23, 2025
Enrollment
20 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd)